Roivant Sciences is planning to launch a Phase 2 clinical trial this year to test its experimental oral therapy…
Articles by Marisa Wexler, MS
Kinevant Sciences’ experimental therapy namilumab failed to show a benefit for people with chronic, active pulmonary sarcoidosis in…
People with sarcoidosis in the U.S. are more likely than those in the general population to have certain co-occurring…
The lungs are affected in nearly everyone diagnosed with sarcoidosis in the Netherlands, but most patients in the country…
Treatment with Remicade (infliximab) is generally effective for controlling sarcoidosis when it affects the nervous system or liver,…
A test that detects disease-specific antibodies in the blood could help to diagnose sarcoidosis more quickly and easily, according…
Acthar Gel (repository corticotropin injection) treats African Americans with sarcoidosis as effectively as it does patients of other…
Scientists at the University of Colorado are planning a study to better classify sarcoidosis as it affects the eyes,…
Having elevated levels of a protein called BNP is associated with an increased risk of death and serious heart health…
Researchers in Austria and the U.K. have created the first mouse model that mimics the human disease of cardiac…